<?xml version="1.0" encoding="UTF-8"?>
<p id="p0185">Globally, the ongoing clinical trials against COVID-19 is carried out at tremendous speed and scale. The fundamental and earlier pathways of vaccine development generally use to take a time scale of 10 years for development. This scenario has changed significantly during the pandemic of Ebola, reducing the time scale to nearly 5 years. At present, several vaccines are pipelined in clinical trials, and several vaccines are in pre-clinical trials.</p>
